Effects of intracoronary propranolol on coronary blood flow and regional myocardial function in dogs

European Journal of Pharmacology
K NoguchiM Sakanashi

Abstract

The study was conducted to evaluate the effects of intracoronary administration of dl-propranolol on coronary blood flow and regional myocardial function in anesthetized open-chest dogs. The results were compared with those obtained with d-propranolol, atenolol and lidocaine. Bolus intracoronary injections of dl-propranolol (0.02-2 mg) dose dependently produced transient increases in coronary blood flow and subsequent depression in regional segment shortening which qualitatively resembled those produced by the dextro isomer (0.02-2 mg) and lidocaine (0.2-10 mg). Atenolol (up to 2 mg) was almost devoid of these effects. Isoproterenol-induced responses were abolished by dl-propranolol and atenolol but only incompletely blocked by d-propranolol. These results demonstrate that propranolol at high doses has direct coronary vasodilating and cardiodepressant effects in situ, and indicate that the major part of these effects can be attributed to the membrane-stabilizing action rather than beta-adrenoceptor blockade.

References

Jun 1, 1989·Cardiovascular Drugs and Therapy·L H Opie
Jul 24, 2014·Journal of Medicinal Food·Marcelo Bezerra MendesAldeídia P Oliveira
Dec 18, 2014·Psychological Medicine·K A KaplanA G Harvey
Jul 14, 2001·The British Journal of Psychiatry. Supplement·J Scott
Jan 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·C J MeakinS R Jones
Aug 1, 1991·Psychological Medicine·D Healy, J M Waterhouse
Oct 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·T A Wehr
Mar 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T Silverstone, S Romans-Clarkson

Citations

Aug 1, 1976·The Journal of Allergy and Clinical Immunology·H M Guirgis, R G Townley
Mar 1, 1975·Cardiovascular Research·R SnyderE S Kirk
Sep 1, 1979·Journal of Cardiovascular Pharmacology·K HashimotoS Imai
Jan 1, 1987·Journal of Cardiovascular Pharmacology·W PolwinK Addicks
Mar 26, 1985·European Journal of Pharmacology·K NoguchiM Sakanashi
Jun 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·J V LEVY, V RICHARDS
Feb 10, 1967·Annals of the New York Academy of Sciences·B R LucchesiJ L Stickney
Jan 1, 1966·Annual Review of Pharmacology·J M Ritchie, P Greengard
Nov 1, 1965·The American Journal of Cardiology·W G Austen, J M Moran
Jun 25, 1966·Nature·R Howe, R G Shanks
Oct 1, 1984·American Heart Journal·A J Wood
Jun 1, 1981·British Journal of Pharmacology·N AkaikeY Oyama
Dec 1, 1983·Journal of the American College of Cardiology·H J DuffR L Woosley
Mar 5, 1981·European Journal of Pharmacology·M Sakanashi, K Nishi
Sep 1, 1963·Anesthesiology·D M STEWARTE F WOODS
May 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·J V LEVY, V RICHARDS
Apr 1, 1965·British Journal of Pharmacology and Chemotherapy·A MORALES AGUILERA, E M VAUGHANWILLIAMS

Related Concepts

Coronary Circulation
Myocardium
Blood Flow
Anterior Thoracic Region
Adrenergic Receptor
Novodrin
Drug Interactions
Chest
Lidocaine
Heart

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.